They found that PGE2 prevented the maturation of dendritic cells (DCs), and the activation of naive CD8+ T cells was terminated; meanwhile, the CD8+ CD28− T cells were induced, and tumor cells could not be killed. This evidence concerns the gene CD28 and neoplasm.